肿瘤肾脏病学:2023核心课程
本文为AJKD核心课程综述,以病例导向方式梳理肿瘤肾脏病学核心概念,涵盖癌症相关急性肾损伤、慢性肾脏病、高血压、蛋白尿和电解质紊乱,以及化疗、免疫治疗、CAR-T和干细胞移植等治疗相关肾损害。
要点
- 肿瘤肾脏病学管理癌症患者的多种肾脏综合征,包括急性肾损伤、慢性肾脏病、高血压、蛋白尿和电解质紊乱。
- 多种肾脏综合征由化疗、免疫治疗、嵌合抗原受体T细胞和干细胞移植等癌症治疗引起。
- 肾脏病患者尤其肾移植受者癌症风险升高,其管理需特殊考量。
核心结论
- 肿瘤肾脏病学以病例为基础,综述癌症相关肾脏病的核心概念与临床决策。
研究设计与样本
- AJKD核心课程综述,采用基于病例的方法突出临床决策。
主要发现
- 癌症可表现为急性肾损伤、慢性肾脏病、高血压、蛋白尿和电解质紊乱等多种肾脏综合征。
- 许多肾脏综合征源于化疗、免疫治疗、嵌合抗原受体T细胞和干细胞移植等癌症治疗。
- 部分肾脏综合征源于癌症对肾脏的特异性效应,如单克隆丙种球蛋白病或恶性肿瘤相关肾小球疾病。
- 肾脏病患者尤其肾移植受者癌症风险升高,其管理需特殊考量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Onconephrology focuses on management of kidney disease in cancer, which manifests itself in a variety of clinical syndromes, including acute kidney injury, chronic kidney disease, hypertension, proteinuria, and electrolyte disorders. Many of these syndromes result from cancer treatments including chemotherapy, immunotherapy, chimeric antigen receptor T cells, and stem cell transplant. Others are due to kidney-specific effects of the cancer, as seen with monoclonal gammopathy or glomerular diseases associated with malignancy. Further, cancer risk itself is heightened in patients with kidney disease, particularly kidney transplant recipients, and their care requires specific considerations. In this installment of AJKD's Core Curriculum in Nephrology, we review these and other core concepts in onconephrology, using a case-based approach to highlight clinical decision making.
引用
- Yarandi N, Shirali AC. Onconephrology: Core Curriculum 2023. Am J Kidney Dis. 2023. PMID: 37855786. doi:10.1053/j.ajkd.2023.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。